loading...| Preferred Name |
nivimedone |
| Synonyms |
5,6-dimethyl-2-nitroindane-1,3-dione, sodium salt |
| ID |
http://purl.bioontology.org/ontology/MESH/C012136 |
| altLabel |
5,6-dimethyl-2-nitroindane-1,3-dione, sodium salt nivimedone sodium nivimedone, sodium salt, monohydrate BRL 10833 1H-indene-1,3(2H)-dione, 5,6-dimethyl-2-nitro |
| cui |
C0107175 C0952452 C0068885 C0132621 |
| HM |
D007189 |
| II |
D001249/Q000188 |
| Inverse of RB |
1M887244YI 4953C873N2 62077-09-2 |
| Mapped to | |
| MDA |
19760101 |
| MeSH Frequency |
10 |
| MMR |
20121105 |
| notation |
C012136 |
| prefLabel |
nivimedone |
| RR |
49561-92-4 (nivimedone) 4953C873N2 62077-09-2 (Na salt.monohydrate) 57441-90-4 (Na salt) |
| SC |
1 |
| Scope Statement |
inhibits mediator release & capillary permeability; RN given refers to parent cpd |
| SRC |
Br J Dis Chest 72(3):225;1978 Lancet 1(8078):1365;1978 Lancet 1(8075):1200;1978 Int Arch Allergy Appl Immunol 51(2):226;1976 Clin Allergy 6:463;1976 Agents Actions 8(3):199;1978 Int Arch Allergy Appl Immunol 60(2):216;1979 Clin Allergy 1979;9(4):373 Clin Allergy 6:471;1976 |
| TERMUI |
T088986 T088985 T088984 T088987 T341758 |
| TH |
FDA SRS (2013) USAN (19XX) USAN (1976) NLM (1976) INN (19XX) |
| tui |
T109 |
| Delete | Mapping To | Ontology | Source |
|---|---|---|---|
| http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C84021 | National Cancer Institute Thesaurus / 美国国家癌症研究所词典 | LOOM |